Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) Equity Average (2023 - 2025)

Upstream Bio (UPB) has 3 years of Equity Average data on record, last reported at $393.7 million in Q3 2025.

  • For Q3 2025, Equity Average rose 356.53% year-over-year to $393.7 million; the TTM value through Sep 2025 reached $393.7 million, up 356.53%, while the annual FY2024 figure was $173.4 million, N/A changed from the prior year.
  • Equity Average reached $393.7 million in Q3 2025 per UPB's latest filing, down from $427.2 million in the prior quarter.
  • Across five years, Equity Average topped out at $457.7 million in Q1 2025 and bottomed at -$153.5 million in Q3 2024.
  • Average Equity Average over 3 years is $111.7 million, with a median of $18.6 million recorded in 2023.
  • Peak YoY movement for Equity Average: soared 231.53% in 2024, then soared 456.86% in 2025.
  • A 3-year view of Equity Average shows it stood at -$117.7 million in 2023, then skyrocketed by 231.53% to $154.8 million in 2024, then surged by 154.35% to $393.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Average were $393.7 million in Q3 2025, $427.2 million in Q2 2025, and $457.7 million in Q1 2025.